Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Hematologic Malignancies

Maria Bhatt

MD

🏢University of Chicago Medicine🌐USA

Associate Professor of Hematologic Oncology

24
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Maria Bhatt is a hematologic oncologist specializing in B-cell lymphoma treatment with bispecific antibodies. She has contributed to trials of glofitamab, epcoritamab, and mosunetuzumab in relapsed/refractory DLBCL and follicular lymphoma. Her translational research investigates pharmacodynamic biomarkers of bispecific antibody activity and the optimal sequencing of bispecific antibodies relative to CAR-T and other immunotherapies.

Share:

🧪Research Fields 研究领域

bispecific antibody lymphoma
CD20 CD3 bispecific lymphoma
glofitamab epcoritamab
mosunetuzumab follicular lymphoma
B-cell lymphoma novel immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Maria Bhatt 的研究动态

Follow Maria Bhatt's research updates

留下邮箱,当我们发布与 Maria Bhatt(University of Chicago Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment